Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion

OBJECTIVE: Evidence for the mucolytic and expectorant efficacy of intravenous (IV) N-acetylcysteine (NAC) is limited. This study aimed to evaluate in a large, multicenter, randomized, controlled, subject, and rater-blinded study whether IV NAC is superior to placebo and non-inferior to ambroxol in improving sputum viscosity and expectoration difficulty. PATIENTS AND METHODS: A total of 333 … Continue reading Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion